CA9 and colorectal adenocarcinoma: This means, that the immunohistochemical detection of the CAIX and survivin in colorectal adenocarcinoma does not provide information about the clinicopathological parameters of the tumor, only about the pathological process or tumorigenesis that has already begun in colorectal tissue.